Portal Instruments is a clinical-stage medical device company, developing a needle-free drug injection platform for subcutaneous delivery of medication for patients suffering from chronic diseases such as ulcerative colitis, multiple sclerosis, rheumatoid arthritis and psoriasis.
Portal Instruments Inc
190 5th Street
Phone / ContactT: +1 617 500 4348
E: [email protected]
Portal Instruments is a clinical stage, medical device company focused on the development and commercialisation of a needle-free injection platform. Portal’s technology is licensed from MIT (Cambridge, MA, US) and is being integrated into a connected drug delivery device for subcutaneous injection.
Portal Instrument’s Prime device offers:
- Needle-free delivery for increased comfort and safety
- Precise, accurate, software controlled delivery
- Connected technology
- Capability to handle high formulation viscosity.
Portal is start-up sized, based in Cambridge (MA, US) and is funded by series B venture capital. The company is privately owned.